These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8218688)

  • 1. An economic evaluation of varicella vaccine for pediatric liver and kidney transplant recipients.
    Kitai IC; King S; Gafni A
    Clin Infect Dis; 1993 Sep; 17(3):441-7. PubMed ID: 8218688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella vaccination in Italy : an economic evaluation of different scenarios.
    Coudeville L; Brunot A; Giaquinto C; Lucioni C; Dervaux B
    Pharmacoeconomics; 2004; 22(13):839-55. PubMed ID: 15329030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of a routine varicella vaccination program for US children.
    Lieu TA; Cochi SL; Black SB; Halloran ME; Shinefield HR; Holmes SJ; Wharton M; Washington AE
    JAMA; 1994 Feb; 271(5):375-81. PubMed ID: 8283587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuated varicella virus vaccine in children with renal transplants.
    Zamora I; Simon JM; Da Silva ME; Piqueras AI
    Pediatr Nephrol; 1994 Apr; 8(2):190-2. PubMed ID: 8018498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella vaccine.
    Med Lett Drugs Ther; 1995 Jun; 37(951):55-7. PubMed ID: 7783692
    [No Abstract]   [Full Text] [Related]  

  • 6. Varicella vaccine in children with chronic renal insufficiency.
    Broyer M; Boudailliez B
    Postgrad Med J; 1985; 61 Suppl 4():103-6. PubMed ID: 3014466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live attenuated varicella virus vaccine. Efficacy trial in healthy children.
    Weibel RE; Neff BJ; Kuter BJ; Guess HA; Rothenberger CA; Fitzgerald AJ; Connor KA; McLean AA; Hilleman MR; Buynak EB
    N Engl J Med; 1984 May; 310(22):1409-15. PubMed ID: 6325909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella vaccination in pediatric kidney and liver transplantation.
    Prelog M; Zimmerhackl LB
    Pediatr Transplant; 2010 Feb; 14(1):41-7. PubMed ID: 20091941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.
    Kawano Y; Suzuki M; Kawada J; Kimura H; Kamei H; Ohnishi Y; Ono Y; Uchida H; Ogura Y; Ito Y
    Vaccine; 2015 Mar; 33(12):1440-5. PubMed ID: 25665961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays.
    Asano Y; Albrecht P; Vujcic LK; Quinnan GV; Kawakami K; Takahashi M
    Pediatrics; 1983 Sep; 72(3):291-4. PubMed ID: 6310478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella-Zoster Virus Pretransplant Vaccination and Posttransplant Infections Among Pediatric Solid Organ Recipients in the Two-Dose Varicella Era: A Single-Center, Multi-Organ Retrospective Study.
    Espinoza-Candelaria GJ; Albert J; Sojati J; Martin JM; Michaels MG; Green M
    Pediatr Transplant; 2024 Aug; 28(5):e14822. PubMed ID: 39054880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella in pediatric patients.
    Drwal-Klein LA; O'Donovan CA
    Ann Pharmacother; 1993; 27(7-8):938-49. PubMed ID: 8395918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of tolerance and effectiveness of a varicella vaccine in leukemic children.
    Bancillon A; Leblanc T; Baruchel A; Schaison G; Leverger G; Mallarmey D; Teuliere L
    Nouv Rev Fr Hematol (1978); 1991; 33(6):555-6. PubMed ID: 1667953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live attenuated varicella vaccine.
    Gershon AA
    Annu Rev Med; 1987; 38():41-50. PubMed ID: 3034136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies.
    Kuter BJ; Weibel RE; Guess HA; Matthews H; Morton DH; Neff BJ; Provost PJ; Watson BA; Starr SE; Plotkin SA
    Vaccine; 1991 Sep; 9(9):643-7. PubMed ID: 1659052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1996 Jul; 45(RR-11):1-36. PubMed ID: 8668119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost containment analysis of childhood vaccination against varicella in Israel.
    Ginsberg GM; Somekh E
    J Infect; 2004 Feb; 48(2):119-33. PubMed ID: 14720487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of Live Attenuated High-Titer Varicella-Zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Aoki T; Koh K; Kawano Y; Mori M; Arakawa Y; Kato M; Hanada R
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):771-775. PubMed ID: 26748161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.